ABSTRACT
Dengue fever is usually a benign acute viral infection transmitted by arthropods but may evolve to severe clinical manifestations such as coagulation and/or hemodynamic disorders, caused mainly by an increase of vascular permeability. Deregulated circulating immunological factors have been associated with severity. In Brazil severe cases appeared in children only recently and we evaluated the profile of cytokine/chemokine kinetics in 134 hospitalized young patients during the epidemic in Rio de Janeiro in 2008. Inflammatory cytokines TNF and IFNγ were found elevated during the acute phase in children as well as the anti-inflammatory IL10 and chemokines MIF and CXCL10/IP10, all last three persisting longer during the recovery phase. Severe disease fitting the dengue hemorrhagic fever pattern (WHO, 1997) was associated with higher IL10 and CXCL10/IP10 circulating levels (peak levels at seven days with P<0.01 and P<0.001 respectively as compared to DF). These factors were higher in patients pulmonary effusion or ascites (P<0.05 for IL10 and P<0.01 for CXCL10/IP10). Both factors were also associated with liver changes such as AST increase correlated with CXCL10/IP10 (r=0.4300 with P<0.0001) and patients presenting painful hepatomegaly showed higher circulating levels of IL10 (P<0.01, at 7-9 days) and of CXCL10/IP10 (P<0.05, 4-6 days and P<0.001, 7-9 days) when compared to patients without apparent liver alterations. Most cases presented a history of prior infection (93%). This is the first study demonstrating cytokine and chemokine association with severity during dengue fever in Brazilian children. IL10 and CXCL10/IP10 play a role in the disease severity associated with induction of vascular leakage and a novel association with changes in liver dysfunction.
Subject(s)
Capillary Permeability/immunology , Chemokines/immunology , Epidemics , Liver Diseases/immunology , Severe Dengue/immunology , Acute Disease , Adolescent , Alanine Transaminase/metabolism , Ascites/etiology , Ascites/immunology , Aspartate Aminotransferases/metabolism , Brazil/epidemiology , Chemokine CXCL10/immunology , Child , Child, Preschool , Cohort Studies , Cytokines/immunology , Dengue/complications , Dengue/epidemiology , Dengue/immunology , Female , Hepatomegaly/etiology , Hepatomegaly/immunology , Humans , Infant , Interferon-gamma/immunology , Interleukin-10/immunology , Interleukin-13/immunology , Intramolecular Oxidoreductases/immunology , Liver Diseases/etiology , Liver Diseases/metabolism , Macrophage Migration-Inhibitory Factors/immunology , Male , Pleural Effusion/etiology , Pleural Effusion/immunology , Retrospective Studies , Severe Dengue/complications , Severe Dengue/epidemiology , Tumor Necrosis Factor-alpha/immunologyABSTRACT
Capillaria hepatica (syn. for Calodium hepaticum) is a zoonotic nematode parasitizing in the livers of rodents as main hosts and in numerous other mammals including humans. It is the causative agent of the rare conditions of hepatic capillariosis and spurious C. hepatica infections in humans. In this review, 163 reported cases of infestations with this parasite (72 reports of hepatic capillariosis, 13 serologically confirmed infestations and 78 observations of spurious infections) are summarized with an overview on the distribution, symptoms, pathology, diagnosis, serology and therapy of this rare human pathogen.
Subject(s)
Capillaria/physiology , Enoplida Infections , Hepatomegaly/parasitology , Life Cycle Stages/physiology , Liver/parasitology , Rodent Diseases , Adult , Africa , Animals , Anthelmintics/administration & dosage , Anthelmintics/therapeutic use , Antibodies, Helminth/analysis , Antibodies, Helminth/immunology , Biopsy , Capillaria/drug effects , Child , Child, Preschool , Disease Reservoirs , Enoplida Infections/diagnosis , Enoplida Infections/epidemiology , Enoplida Infections/immunology , Enoplida Infections/mortality , Enoplida Infections/parasitology , Enoplida Infections/pathology , Enoplida Infections/physiopathology , Enoplida Infections/therapy , Enzyme-Linked Immunosorbent Assay , Europe , Female , Hepatomegaly/immunology , Hepatomegaly/pathology , Hepatomegaly/physiopathology , Humans , Infant , Life Cycle Stages/drug effects , Liver/immunology , Liver/pathology , Liver/physiopathology , Male , North America , Phylogeography , Rodent Diseases/diagnosis , Rodent Diseases/epidemiology , Rodent Diseases/immunology , Rodent Diseases/mortality , Rodent Diseases/parasitology , Rodent Diseases/pathology , Rodent Diseases/physiopathology , Rodentia , South America , Survival Rate , Tomography, X-Ray ComputedABSTRACT
Schistosomal nephropathy has long been related to the hepatosplenic form of schistosomiasis. In the last few years, 24 patients with hepatointestinal schistosomiasis and the nephrotic syndrome were studied. Aiming at evaluating a possible etiologic participation of schistosomiasis in the development of the nephropathy, this group was comparatively studied with a group of 37 patients with idiopathic nephrotic syndrome. Both groups had a different distribution of the histologic lesions. In the group with schistosomiasis there was a statistically significant prevalence of proliferative mesangial glomerulonephritis (33.3%), whereas in the control group there was prevalence of membranous glomerulonephritis (32.4%). On immunofluorescence, IgM was positive in 94.4% of the patients with schistosomiasis versus 55.0% in the control group (P < 0.01). In the group with schistosomiasis, 8 patients evidenced mesangial proliferative glomerulonephritis and 5, membranoproliferative glomerulonephritis. In both histological types immunofluorescence showed IgM and C3 granular deposits in the glomeruli. The data in this study suggests that mesangial proliferative and membranoproliferative glomerulonephritis, with glomerular granular IgM and C3 deposits, represent the renal lesions of the schistosomiasis associated nephropathy.
Subject(s)
Hepatomegaly/complications , Nephrotic Syndrome/etiology , Schistosomiasis mansoni/complications , Adolescent , Adult , Biopsy, Needle , Chi-Square Distribution , Complement C3/metabolism , Female , Hepatomegaly/epidemiology , Hepatomegaly/immunology , Hepatomegaly/pathology , Humans , Immunoglobulin M/metabolism , Kidney/immunology , Kidney/pathology , Male , Microscopy, Fluorescence , Middle Aged , Nephrotic Syndrome/epidemiology , Nephrotic Syndrome/immunology , Nephrotic Syndrome/pathology , Schistosomiasis mansoni/epidemiology , Schistosomiasis mansoni/immunology , Schistosomiasis mansoni/pathologyABSTRACT
Schistosomal nephropathy has long been related to the hepatosplenic form of schistosomiasis. In the last few years, 24 patients with hepatointestinal schistosomiasis and the nephrotic syndrome were studied. Aiming at evaluating a possible etiologic participation of schistosomiasis in the development of the nephropathy, this group was comparatively studied with a group of 37 patients with idiopathic nephrotic syndrome. Both groups had a different distribution of the histologic lesions. In the group with schistosomiasis there was a statistically significant prevalence of proliferative mesangial glomerulonephritis (33.3%), whereas in the control group there was prevalence of membranous glomerulonephritis (32.4%). On immunofluorescence, IgM was positive in 94.4% of the patients with schistosomiasis versus 55.0% in the control group (P < 0.01). In the group with schistosomiasis, 8 patients evidenced mesangial proliferative glomerulonephritis and 5, membranoproliferative glomerulonephritis. In both histological types immunofluorescence showed IgM and C3 granular deposits in the glomeruli. The data in this study suggests that mesangial proliferative and membranoproliferative glomerulonephritis, with glomerular granular IgM and C3 deposits, represent the renal lesions of the schistosomiasis associated nephropathy
Subject(s)
Humans , Male , Female , Hepatomegaly/complications , Nephrotic Syndrome/etiology , Schistosomiasis mansoni/complications , Adolescent , Adult , Biopsy, Needle , Chi-Square Distribution , Complement C3/metabolism , Hepatomegaly/epidemiology , Hepatomegaly/immunology , Hepatomegaly/pathology , Immunoglobulin M/metabolism , Kidney/immunology , Kidney/pathology , Microscopy, Fluorescence , Middle Aged , Nephrotic Syndrome/epidemiology , Nephrotic Syndrome/immunologySubject(s)
Hepatomegaly/immunology , Interleukin-2/metabolism , Schistosomiasis mansoni/immunology , Splenomegaly/immunology , T-Lymphocytes/immunology , Tumor Necrosis Factor-alpha/metabolism , Adolescent , Adult , Aged , Child , Hepatomegaly/etiology , Humans , Lymphocyte Activation , Middle Aged , Schistosomiasis mansoni/complications , Splenomegaly/etiology , T-Lymphocytes/metabolismABSTRACT
The sequence of antibody production to various virus-specific antigens in CMV infection in infancy was studied. In healthy infants, IgG EA antibody was demonstrated in 18% of cord sera, and disappeared within two months after birth in all cases not shedding virus. The nonmaternal EA antibody was produced following virus excretion and decreased rapidly following cessation of virus excretion. Thus, demonstration of EA antibody in infants after 2 months of age was found to indicate acquired CMV infection, even when CMV could not be isolated. IgM MA antibody did not persist as long as EA antibody, disappearing before cessation of virus excretion. Both IgG EA and IgM MA antibodies were more frequently demonstrated in infants with hepatitis than in healthy infants. These findings suggest the possible association of CMV with hepatitis in infants.
Subject(s)
Antibodies, Viral/analysis , Cytomegalovirus Infections/immunology , Immunoglobulin G/immunology , Immunoglobulin M/immunology , Liver Diseases/immunology , Antigens, Viral/immunology , Cell Membrane/immunology , Cholestasis, Extrahepatic/immunology , Cholestasis, Intrahepatic/immunology , Cytomegalovirus/immunology , Cytomegalovirus/metabolism , Cytomegalovirus Infections/diagnosis , Hepatomegaly/immunology , Humans , Infant , Splenomegaly/immunologySubject(s)
Immunity, Cellular , Immunoglobulins/analysis , Schistosoma mansoni/immunology , Schistosomiasis/immunology , Adolescent , Child , Female , Hepatomegaly/etiology , Hepatomegaly/immunology , Humans , Hypersensitivity, Delayed , Immunoglobulin A/analysis , Immunoglobulin G/analysis , Immunoglobulin M/analysis , Male , Nitrobenzenes , Schistosomiasis/complications , Serum Albumin/analysis , Serum Globulins/analysis , Skin Tests , Splenomegaly/etiology , Splenomegaly/immunology , West IndiesABSTRACT
An investigation was made of the immunological status of matched groups of patients with Schictosoma mansoni infection in St. Lucia, one group with hepatosplenic disease and the other with only intestinal disease. No impairment of humoral or cellular immunity was detected in either group. IgG and IgM levels were above normal range and were higher in the patients with intestinal disease, but only the difference between groups in IgG level was statistically significant. In their reaction to specific schistisome antigens and ability to develop delayed hypersensitivity, the groups were about equal. (AU)